What We Don't Claim (And Why)
Honest supplement companies tell you what their products can't do. Here is every claim we deliberately don't make — and the exact regulatory or scientific reason behind each one.
In a market built on exaggeration, honesty is radical. When you see "Supports normal cognitive function" instead of "Boosts IQ", you know two things: we're not overclaiming, and the claim is EFSA-approved. Restricted language is a feature, not a weakness.
"Prevents Aging"
SirtCore™ 01Aging is not a disease; it is a biological process. EFSA does not recognise "anti-aging" as an approvable health claim.
Supports cellular energy metabolism (NAD+ pathway support via Nicotinamide)
EFSA Journal 2010;8(10):1757
"Increases NAD+ Levels"
SirtCore™ 01 / Cell-ReviveEFSA has not approved a health claim for increasing NAD+ levels from supplement ingredients. The approved claim is for the precursor's role in energy metabolism.
Contains Nicotinamide (Vitamin B3), which contributes to normal energy-yielding metabolism
EFSA Journal 2010;8(10):1757
"Reduces Cortisol"
Cortisol ShieldCortisol is not a pathogen — it is a necessary hormone. Suppression claims imply treatment of a medical condition.
Supports healthy relaxation and normal sleep quality. Magnesium contributes to normal functioning of the nervous system.
EFSA Journal 2009;7(9):1216
"Lose Weight / Burn Fat"
Gut-Metabolic AssistDirect weight loss outcome claims for supplements are restricted under EFSA Regulation 1924/2006. The approved glucomannan claim requires specific conditions.
Glucomannan contributes to the maintenance of normal blood cholesterol levels (4g/day). Supports healthy appetite regulation and normal energy metabolism.
EFSA Journal 2009;7(9):1159
"Cure Insomnia / Treat Sleep Disorders"
Cortisol ShieldSleep disorders require medical diagnosis and treatment. Supplements support wellness — they do not treat medical conditions.
Supports healthy relaxation and normal sleep quality. Magnesium contributes to a reduction of tiredness and fatigue.
EFSA Journal 2009;7(9):1216
"Boosts Brain Power / Enhances Intelligence"
Neuro-Stack NDO-X / NeuroTide™ FocusCognitive enhancement is not an approved EFSA claim category. Specific approved claims exist for contributing to normal cognitive function.
Zinc contributes to normal cognitive function. DHA contributes to the maintenance of normal brain function.
EFSA Journal 2014;12(5):3697 • EFSA Journal 2010;8(10):1734
"Better Than [Competitor]"
All productsComparative claims are prohibited without rigorous substantiation under EFSA Regulation 1924/2006. We cannot claim to be superior to named brands.
Precision formulation with 4–7 clinical ingredients at EFSA-compliant doses. Full transparency on sourcing and batch verification.
EFSA Regulation 1924/2006 (comparative claims)
"Skincare You Drink" (as a medical beauty claim)
Glow MatrixSuggesting a supplement replaces or rivals topical skincare implies a medical intervention claim.
Collagen-based formula supporting healthy skin hydration and connective tissue structure. Vitamin C contributes to normal collagen formation for the normal function of skin.
EFSA Journal 2009;7(9):1226
This Is Not a Limitation — It's Our Competitive Advantage
For You
You know exactly what is substantiated. No surprises when EFSA updates its guidance. Ingredients are genuinely therapeutic — at clinical doses.
For Health Professionals
Supplements become part of evidence-based practice — not wellness theater. Doctors, nutritionists, and coaches can recommend Moana with confidence.
For Europe
Competition moves toward evidence, not hype. A supplement market where claims are verified builds consumer trust in the entire category.
Want to Understand the Full Picture?
Read how we select, dose, and update every ingredient — including the ones we include without making claims.
Food Supplements. Our products are not intended to diagnose, treat, cure, or prevent any disease. All health claims comply with EFSA Regulation 1924/2006 and EU Regulation 432/2012. EFSA Journal references verifiable at efsa.europa.eu.